Shape shifters: Biobehavioral determinants and phenomena in symptom research

Nursing Outlook

Volumn 60, Issue 4, 2012, Pages 191-197

  Corwin, Elizabeth J ^a   Meek, Paula ^b   Cook, Paul F ^b   Lowe, Nancy K ^b   Sousa, Karen H ^b  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Behavioral; Biobehavioral research; Biological; Determinants; Phenomena; Shape shifters; Symptom cluster; Symptoms

Indexed keywords

ARTICLE; BEHAVIOR; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CLINICAL NURSING RESEARCH; CLUSTER ANALYSIS; HUMAN; METHODOLOGY; NOMENCLATURE; NURSING ASSESSMENT;

BEHAVIORAL SYMPTOMS; BIOLOGICAL PHENOMENA; CLINICAL NURSING RESEARCH; CLUSTER ANALYSIS; HUMANS; NURSING ASSESSMENT; TERMINOLOGY AS TOPIC;

EID: 84863762284     PISSN: 00296554     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.outlook.2012.04.008     Document Type: Article

References (36)

1. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 2003, 30:386-389.
2. Karg K., Burmeister M., Snedden K., Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 2011, 68:444-454.
3. Cannon M.J., Hyde T.B., Schmid D.S. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol 2011, 21:240-255.
4. Lombardi G., Garofoli F., Stronati M. Congenital cytomegalovirus infection: Treatment, sequelae and follow-up. J Matern Fetal Neonatal Med 2010, 23(Suppl 3):45-48.
5. Gailliot M.T., Baumeister R.F. The physiology of willpower: Linking blood glucose to self-control. Pers Soc Psych Rev 2007, 11:303-327.
6. Chrousos G.P., Gold P.W. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992, 267:1244-1252.
7. Riether C., Doenlen R., Pacheco-Lopez G., Niemi M.-B., Engler A., Engler H., et al. Behavioural conditioning of immune functions: How the central nervous system controls peripheral immune responses by evoking associative learning processes. Rev Neurosci 2008, 19:1-17.
8. Webster Marketon J.I., Glaser R. Stress hormones and immune function. Cell Immunol 2008, 252:16-26.
9. Benedetti F. Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu Rev Pharmacol Toxicol 2008, 48:33-60.
10. Howland R.H. Understanding the placebo effect. Part 2: Underlying psychological and neurobiological processes. J Psychosoc Nurs Ment Health Serv 2008, 46:15-18.
11. Dyspnea. Mechanisms, assessment, and management: A consensus. Am J Respir Crit Care Med 1999, 159:323. American Thoracic Society.
12. Greenberg M.J., Mealy T.R., Jones M., Szczesna-Cordary D., Moore J.R. The direct molecular effects of fatigue and myosin regulatory light chain phosphorylation on the actomyosin contratile apparatus. Am J Physiol Regul Integr Comp Physiol 2010, 298:R989-R996.
13. Marcora S.M., Staiano W., Manning V. Mental fatigue impairs physical performance in humans. J Appl Physiol 2009, 106:857-864.
14. National Institutes of Health. PROMIS: Patient-Reported Outcomes Measurement Information System. 2011. Available at Accessed October 2011. http://commonfund.nih.gov/promis.
15. Romer L.M., Polkey M.I. Exercise-induced respiratory muscle fatigue: Implications for performance. J Appl Physiol 2008, 104:879-888.
16. Taylor J.L., Gandevia S.C. A comparison of central aspects of fatigue in submaximal and maximal voluntary contractions. J Appl Physiol 2008, 104:542-550.
17. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946.
18. McConnell A.K., Romer L.M. Dyspnea in health and obstructive pulmonary disease: The role of respiratory muscle function and training. Sports Med 2004, 34:117-132.
19. Supinski G.S., Clary S.J., Bark H., Kelson S.G. Effect of inspiratory muscle fatigue on perception of effort during loaded breathing. J Appl Physiol 1987, 62:300-307.
20. Corwin E.J. Understanding cytokines. Part II: Implications for nursing research and practice. Biol Res Nurs 2000, 2:41-48.
21. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Revs Neurosci 2008, 9:46-56.
22. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65:732-741.
23. Owen B.M., Eccleston D., Ferrier I.N., Young A.H. Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Neurol Scand 2001, 103:226-228.
24. Vollmer-Conna U., Fazou C., Cameron B., Li H., Brennan C., Luck L., et al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 2004, 34:1289-1297.
25. Moss-Morris R., Weinman J., Petrie K., Horne R., Cameron L., Buick D. The Revised Illness Perception Questionnaire (IPQ-R). Psychol Health 2002, 17:1-16.
26. Beck A.T., Steer R.A., Ball R., Ranieri W.F. Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Pers Assess 1996, 67:588-597.
27. Ickovics J.R., Cameron A., Zackin R., Bassett R., Chesney M., Johnson V.A., et al. Adult AIDS Clinical Trials Group 370 Protocol Team. Consequences and determinants of adherence to antiretroviral medication: Results from Adult AIDS Clinical Trials Group protocol 370. Antivir Ther 2002, 7:185-193.
28. Levensky E.R., O'Donohue W.T. Patient adherence and nonadherence to treatments. Promoting Treatment Adherence: A Practical Handbook for Health Care Providers 2006, Sage, Thousand Oaks, CA. W.T. O'Donohue, E.R. Levensky (Eds.).
29. Sanson-Fisher R., Bowman J., Armstrong S. Factors affecting nonadherence with antibiotics. Diagn Microbiol Infect Dis 1992, 15:103-109.
30. Antonelli-Incalzi R., Corsonello A., Trojano L., Acanfora D., Spada A., Izzo O., et al. Correlation between cognitive impairment and dependence in hypoxemic COPD. J Clin Exp Neuropsychol 2008, 30:141-150.
31. Incalzi R.A., Gemma A., Marra C., Capparella O., Fuso L., Carbonin P. Verbal memory impairment in COPD: Its mechanisms and clinical relevance. Chest 1997, 112:1506-1513.
32. Cully J.A., Graham D.P., Stanley M.A., Ferguson C.J., Sharafkhaneh A., Souchek J., et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2006, 47:312-319.
33. Miaskowski C., Aouizerat B.E., Dodd M., Cooper B. Conceptual issues in symptom clusters research and their implications for quality-of-life assessment in patients with cancer. J Natl Cancer Inst Monogr 2007, 37:39-46.
34. Pirraglia P.A., Casserly B., Velasco R., Borgia M.L., Nici L. Association of change in depression and anxiety symptoms with functional outcomes in pulmonary rehabilitation patients. J Psychosom Res 2011, 71:45-49.
35. von Leupoldt A., Taube K., Lehmann K., Fritzsche A., Magnussen H. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest 2011, 140:730-736.
36. Miaskowski C., Dodd M., Lee K. Symptom clusters: the new frontier in symptom management research. J Natl Cancer Inst Monogr 2004, 32:17-21.